Central Nervous System International Prognostic Index (CNS-IPI)

The CNS‑IPI estimates the risk of secondary CNS relapse in DLBCL using the five IPI factors plus kidney/adrenal involvement 1.

Age > 60 years
No0Yes+1
LDH > normal
No0Yes+1
ECOG Performance Status > 1
No0Yes+1
Ann Arbor stages III or IV
No0Yes+1
> 1 extranodal disease site
No0Yes+1
Kidney and/or adrenal gland involvement
No0Yes+1

使用適応

Used to identify DLBCL patients at elevated risk of CNS relapse and guide need for CNS prophylaxis or baseline CNS staging. High‑risk score (4–6) predicts ~10–12% 2‑year CNS relapse risk 1 [Level I evidence]. Recommended when evaluating patients for CNS prophylaxis per ESMO guidance 2 [Level I evidence]. Highest utility is ruling out low‑risk patients and flagging those needing CNS-directed evaluation.

洞察と注意事項

Identifies DLBCL patients at highest CNS‑relapse risk using age, LDH, stage, ECOG, extranodal sites, and kidney/adrenal involvement; high‑risk scores carry ~10–12% 2‑year relapse risk 1 [Level I evidence]. Useful for excluding low‑risk patients from unnecessary prophylaxis, but has low positive predictive value and misses events in low‑intermediate groups 2 [Level II evidence]. Underperforms when molecular (ABC/unclassified) features drive risk 3 [Level II evidence].